Clinical Research
Learn More about Basic Research within the Division
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Division of Pediatric Endocrinology and Diabetes at Stanford is actively involved in clinical research. The department has several on-going studies, as well as ones that are open for enrollment. If you are interested in being contacted about future studies, please sign the Patient List Research Consent Form. Once completed, please return it at your next clinic appointment or by mail to the following:
Bonita Baker
Division of Pediatric Endocrinology and Diabetes
Stanford University School of Medicine
Room G-313 Medical Center
300 Pasteur Drive
Stanford, CA, USA 94305-5208
Subject Recruitment
The following studies are currently recruiting study subjects. Please click on the study title for more information.
Study Title |
Looking for... |
Relatives of people with type 1 diabetes. First degree blood relatives ages 1-45 and second degree relatives ages 1-20. |
|
Type 1 Diabetes TrialNet: Oral Insulin Study
|
Relatives of people with type 1 diabetes. Start with the Pathway to Prevention Study |
| Relatives of people with type 1 diabetes. Start with the Pathway to Prevention Study | |
| Type I Diabetes TrialNet Protocol TN-10, Anti-CD3 mAb (Teplizumab) for Prevention of Diabetes in Relatives At-Risk for Type 1 Diabetes Mellitus |
Relatives of people with type 1 diabetes. Start with the Pathway to Prevention Study |
| The T1D Exchange Type 1 Diabetes Network | Individuals with type 1 diabetes. |
Nocturnal Camp Closed-Loop with Medtronic ePID Controller The OCL Camp Study |
Individuals with type 1 diabetes attending summer camp in 2013 - for more information - contact Paula Clinton -650-736-2313 or pclinton@stanford.edu |
| Below are studies we generally offer to potential subjects during a clinical visit | |
| Shared Medical Visits | Consent Assent Handout |
| TN LIFT (longterm followup) | Consent Assent Handbook |
| Nocturnal Hypoglycemia Prevention | Consent |
| Agenesis Project | Consent Assent |
| DKA Brain Compliance Device | Consent Assent |
| DKA Neurocognition | Consent Assent Handout |
| Diabetes Antibody Assay Development | Consent Assent Short Form |
| Diabetes Etiology Sample | Consent Assent Short Form |
| Glucagon Control | Consent |
| Aromatase Inhibitor Growth Study | Growth study for pubertal MALES older than 10 years. |
| Development of Algorithms for a Prototype Closed Loop Insulin Pump (Closed Loop 1) | Patients with type 1 diabetes ages 3-31 who were diagnosed within the past year and are currently using an insulin pump. |
| Sponsored multicenter depot lupron study | |
| Depot Lupron Study | Patients with newly diagnosed Central Precocious Puberty who have not started medical therapy. |
| Comparison of transdermal and oral estrogens in adolescents with ovarian failure |
Consent Assent |
| General Use of a Glucose Sensor | Consent Assent |
| Growth Hormone Therapy | Patients and families who are interested in growth hormone
therapy should be evaluated by a pediatric endocrinologist to determine
appropriateness of treatment. Risks and benefits of growth hormone therapy are reveiwed in the consent form. |
| Pediatric Intensive Care Unit Project | Patients hospitalized in the pediatric intensive care unit with hyperglycemia within the past 12 hours. |
Control of Transplant related hyperglycemia |
|
| Pamidronate Therapy for Children | Consent Assent |
| Data collection protocol | |
| Vitamin D study | |
| This is an IRB approved protocol to allow Stanford to do some tests required of OUTSIDE protocols here at Stanford when appropriate. |
Please check back for study updates and the addition of new studies.
